Morgan Stanley’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.4M Sell
967,120
-181,962
-16% -$2.9M ﹤0.01% 3311
2025
Q4
$18.7M Buy
1,149,082
+77,012
+7% +$1.26M ﹤0.01% 3007
2025
Q3
$16M Sell
1,072,070
-225,874
-17% -$2.75M ﹤0.01% 3098
2025
Q2
$15.1M Buy
1,297,944
+172,683
+15% +$1.57M ﹤0.01% 3074
2025
Q1
$8.36M Sell
1,125,261
-68,574
-6% -$527K ﹤0.01% 3505
2024
Q4
$7.16M Buy
1,193,835
+145,703
+14% +$803K ﹤0.01% 3684
2024
Q3
$5.37M Buy
1,048,132
+531,672
+103% +$2.32M ﹤0.01% 3907
2024
Q2
$1.87M Sell
516,460
-152,670
-23% -$485K ﹤0.01% 4613
2024
Q1
$2.15M Sell
669,130
-1,218,468
-65% -$4.71M ﹤0.01% 4531
2023
Q4
$9.25M Buy
1,887,598
+1,482,815
+366% +$6.77M ﹤0.01% 3981
2023
Q3
$2.21M Sell
404,783
-255,730
-39% -$1.69M ﹤0.01% 4331
2023
Q2
$4.43M Sell
660,513
-53,409
-7% -$397K ﹤0.01% 3866
2023
Q1
$6.3M Sell
713,922
-693,768
-49% -$6.12M ﹤0.01% 3579
2022
Q4
$10.8M Buy
1,407,690
+386,229
+38% +$3M ﹤0.01% 3010
2022
Q3
$7.27M Sell
1,021,461
-125,905
-11% -$1.19M ﹤0.01% 3305
2022
Q2
$9.28M Buy
1,147,366
+640,112
+126% +$5.63M ﹤0.01% 3137
2022
Q1
$7.04M Buy
507,254
+115,575
+30% +$1.82M ﹤0.01% 3310
2021
Q4
$11M Sell
391,679
-72,950
-16% -$2.24M ﹤0.01% 2850
2021
Q3
$15.8M Sell
464,629
-29,194
-6% -$1.06M ﹤0.01% 2347
2021
Q2
$20.2M Sell
493,823
-102,969
-17% -$4M ﹤0.01% 2137
2021
Q1
$24M Buy
596,792
+170,882
+40% +$9.25M ﹤0.01% 1745
2020
Q4
$25.2M Buy
425,910
+128,564
+43% +$6.63M ﹤0.01% 1594
2020
Q3
$14.5M Buy
297,346
+83,804
+39% +$3.52M ﹤0.01% 1713
2020
Q2
$10.3M Sell
213,542
-10,840
-5% -$395K ﹤0.01% 1934
2020
Q1
$6.23M Buy
224,382
+11,993
+6% +$335K ﹤0.01% 2238
2019
Q4
$6.36M Buy
212,389
+41,216
+24% +$1.18M ﹤0.01% 2921
2019
Q3
$5.29M Buy
171,173
+20,086
+13% +$820K ﹤0.01% 2824
2019
Q2
$7.3M Buy
+151,087
New +$6.69M ﹤0.01% 2507

Other funds holding ADPT